PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
09-Apr-2024 Mainz Biomed Reports Full Year 2023 Financial Results Mainz BioMed N.V.
09-Apr-2024 Medacta publishes 2024 Annual General Meeting invitation Medacta Group SA
08-Apr-2024 Biophytis announces its 2023 financial results and provides an update on its business activities Biophytis
08-Apr-2024 Biophytis announces its 2023 financial results and provides an update on its business activities Biophytis
08-Apr-2024 Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone) Biophytis
08-Apr-2024 Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) Newron Pharmaceuticals S.p.A.
05-Apr-2024 Abivax publishes financial reports with the French and U.S. securities regulatory agencies ABIVAX
05-Apr-2024 Almac Pharma Services Appoints New Director of Manufacturing Science and Technology Almac Pharma
05-Apr-2024 Heidelberg Pharma to host R&D Webinar following novel data presented at AACR Heidelberg Pharma
05-Apr-2024 AlzeCure Pharma publishes its Annual Report for 2023 AlzeCure Pharma
05-Apr-2024 MEDICLIN buys Reha-Klinik am Sendesaal MEDICLIN AG
05-Apr-2024 Chiesi’s carbon minimal inhalers reach innovation milestone as phase III trials now underway Chiesi
05-Apr-2024 APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast APONTIS PHARMA AG
05-Apr-2024 APONTIS PHARMA AG raises forecast after entering five-year distribution and marketing agreement with Novartis for two asthma medications APONTIS PHARMA AG
05-Apr-2024 Heidelberg Pharma to host R&D Webinar following novel data presented at AACR Heidelberg Pharma AG
04-Apr-2024 RESULTS OF THE COMBINED GENERAL MEETING ON APRIL 2, 2024 Biophytis
04-Apr-2024 CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK CureVac
04-Apr-2024 Medartis successfully places CHF 115.8 million convertible bonds due 2031 Medartis Holding AG
03-Apr-2024 Astex Pharmaceuticals Announce Key Data Presentations at the American Association For Cancer Research (AACR) 2024 Annual Meeting Astex Pharmaceuticals
03-Apr-2024 ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024 ADC Therapeutics